Literature DB >> 7091383

Noncompartmental vs. compartmental analysis: some bases for choice.

J J DiStefano.   

Abstract

The physical conditions that govern the applicability of noncompartmental analysis methods apparently are not all completely appreciated in the user community. This increasingly popular approach to kinetic analysis is not "model independent," as it is often called, and if it is used, for example, for substances synthesized in pools not accessible to direct test-input probes, or substances metabolized in pools inaccessible to direct measurement, results will be more or less in error. STrictly speaking, all endogenous sources (e.g., secretions) and all sinks (e.g., catabolism) each must be uniquely associated with the same (central) pool(s) into which test inputs are introduced, the same pool(s) where all measurements must be made. The consequences of not meeting these conditions are explored by evaluating the errors committed in estimating distribution volumes VD, plasma (metabolic) clearance rates PCR, and mean residence or transit times t, in mammillary-connected systems of arbitrary size (as an example), in which sources and sinks exist in one or more noncentral pools. It is shown that noncompartmental analysis always underestimates VD and t under any such conditions, and PCR is underestimated if there are noncentral sources. Formulas for the errors are given, which could be large or small depending on several complex factors not easy to discern without additional information about the system.

Mesh:

Year:  1982        PMID: 7091383     DOI: 10.1152/ajpregu.1982.243.1.R1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin.

Authors:  Alison K Meagher; Alan Forrest; Axel Dalhoff; Heino Stass; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study.

Authors:  Marisa C Eisenberg; Harsh V Jain
Journal:  J Theor Biol       Date:  2017-07-19       Impact factor: 2.691

Review 4.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

5.  Some clarifications regarding moments of residence times with pharmacokinetic models.

Authors:  S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

6.  Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

7.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

8.  The concept of half-life of hormone.

Authors:  B Liu; J Peng; Y Liu
Journal:  Med Biol Eng Comput       Date:  1995-11       Impact factor: 2.602

9.  Comments on mean residence time determination.

Authors:  E M Landaw; D Katz
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

10.  Similar effect of oxidation deficiency (debrisoquine polymorphism) and quinidine on the apparent volume of distribution of (+/-)-metoprolol.

Authors:  T D Leemann; K P Devi; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.